Anxin Drink in the Treatment of Microvascular Angina with Qi Stagnation and Blood Stasis Syndrome

Puntos clave

• The study aims to evaluate the clinical efficacy of Anxin Drink in treating microvascular angina characterized by Qi stagnation and blood stasis syndrome.
• Randomized controlled trial with 60 patients suffering from microvascular angina
• Patients divided into a control group receiving standard Western treatment and a test group receiving Anxin Drink
• Assessment of clinical efficacy, traditional Chinese medicine symptom scores, and levels of biochemicals like NO, MMP-9, hs-CRP, TNF-α, and IL-6
• The test group showed a significantly better clinical efficacy than the control group (P<0.05)
• Post-treatment, the test group's TCM symptom scores were lower than the control group (P<0.05)
• NO levels in the test group were higher, while MMP-9, hs-CRP, TNF-α, and IL-6 levels were lower than the control group (P<0.05)

Resumen